( January 7, 2025, 8:31 AM EST) -- NEWARK, N.J. — A New Jersey federal judge denied a motion to strike a fourth amended complaint alleging that three drug manufacturers engaged in an unfair and unconscionable pricing scheme for their analog insulin products but agreed to dismiss certain claims....